322 filings
Page 3 of 17
D
gsxlg6qvc
4 May 22
$866.25K in equity, sold $866.25K, 2 investors
8:17am
8-K
0d6f2 r4orhz9y8rmn
27 Apr 22
Xenetic Biosciences, Inc. Expands Oncology Pipeline with In-Licensing of DNase Based Oncology Platform Comprising Multiple Therapeutic Modalities
6:30am
8-K
bqbwn40f cvuhtvg3
23 Mar 22
Xenetic Biosciences, Inc. Reports Full Year 2021 Financial Results and Provides Business Update
8:30am
S-8
dzu1068hri zpy1xiuv1
30 Dec 21
Registration of securities for employees
4:31pm
8-K
nt13lbm
9 Dec 21
Submission of Matters to a Vote of Security Holders
5:00pm
DEFA14A
rof5m
2 Dec 21
Additional proxy soliciting materials
4:30pm
8-K
43ky21yc
19 Nov 21
Entry into a Material Definitive Agreement
4:55pm
424B5
hvn blokes28
19 Nov 21
Prospectus supplement for primary offering
4:54pm
8-K
b9rto
16 Nov 21
Entry into a Material Definitive Agreement
8:30am
8-K
gglm irdn
12 Nov 21
Xenetic Biosciences, Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update
8:00am
EFFECT
g41m8ik drg
25 Oct 21
Notice of effectiveness
12:15am
S-3/A
jusuv4 9bwl3it
20 Oct 21
Shelf registration (amended)
4:30pm
CORRESP
ndc66jdogtl wq
20 Oct 21
Correspondence with SEC
12:00am
UPLOAD
rj12qm
19 Oct 21
Letter from SEC
12:00am
8-K
0lvh88yimv7 8w2gions
15 Oct 21
Entry into a Material Definitive Agreement
4:30pm